U.S. advisers back experimental obesity pill
(Reuters)
[unable to retrieve full-text content]Reuters - Experimental obesity drug Qnexa won the backing of U.S. health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.